VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate CancerDaniela Barros‐Silva, Cármen Jerónimo, João Lobo et al.|Cancers|2020Cited by 85
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda‐Gonçalves, Cármen Jerónimo, João Lobo et al.|Journal of Experimental & Clinical Cancer Research|2021Cited by 59
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell TumorsJoão Lobo, Cármen Jerónimo, Mariana Cantante et al.|Cancers|2020Cited by 38
Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor SubtypesCatarina Guimarães‐Teixeira, Cármen Jerónimo, Daniela Barros‐Silva et al.|Journal of Personalized Medicine|2021Cited by 27
Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transitionSara Monteiro‐Reis, Cármen Jerónimo, Vera Miranda‐Gonçalves et al.|International Journal of Biological Sciences|2022Cited by 25